Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population

被引:5
|
作者
Chen, Boyang [1 ]
Wang, Yafeng [2 ]
Tang, Weifeng [3 ]
Chen, Yu [4 ]
Liu, Chao [5 ]
Kang, Mingqiang [1 ,6 ]
Xie, Jinbiao [1 ]
机构
[1] Putian Univ, Affiliated Hosp, Dept Cardiothorac Surg, Putian 351100, Fujian, Peoples R China
[2] Peoples Hosp Xishuangbanna Dai Autonomous Prefectu, Dept Cardiol, Jinghong, Yunnan, Peoples R China
[3] Nanjing Univ, Nanjing Drum Tower Hosp, Dept Cardiothorac Surg, Affiliated Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China
[4] Fujian Med Univ, Fujian Canc Hosp, Dept Med Oncol, Canc Hosp, Fuzhou, Fujian, Peoples R China
[5] Jiangsu Univ, Dept Cardiothorac Surg, Affiliated Peoples Hosp, Zhenjiang, Jiangsu, Peoples R China
[6] Fujian Med Univ, Dept Thorac Surg, Union Hosp, Fuzhou 350001, Fujian, Peoples R China
关键词
PPAR gamma; PPARGC1A; PPARGC1B; Variant; SNVs; Gastric cancer; ACTIVATED RECEPTOR-GAMMA; SINGLE-NUCLEOTIDE POLYMORPHISMS; COLORECTAL-CANCER; PRO12ALA POLYMORPHISM; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; TARGET GENES; COACTIVATOR; RISK; EXPRESSION;
D O I
10.1186/s12920-022-01428-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Previous studies showed that peroxisome proliferator-activated receptor gamma (PPAR gamma) and PPAR gamma coactivator1 family (PPARGC1A and PPARGC1B) gene single nucleotide variants (SNVs)were strongly associated with cancer susceptibility. The purpose of this study was to investigate the association of PPAR gamma, PPARGC1A, and PPARGC1B variants with the risk of gastric cancer (GC). Patients and methods: We performed a case-control study of 490 GC cases and 1,476 healthy controls from eastern China. PPAR gamma rs1801282 C > G, rs3856806 C > T, PPARGC1A rs2970847 C > T, rs8192678 C > T and PPARGC1B rs7732671 G > C, rs17572019 G > A SNVs were selected to investigate the association between these SNVs and GC susceptibility. Genotypes of the SNVs were assessed by multiplex fluorescent PCR using a custom-by-design 48-Plex SNPscan (TM) Kit. Results: The PPAR gamma rs1801282 SNV was associated with a decreased risk for GC (GC vs. CC: odds ratio (OR) = 0.62, 95% confidence interval (95%CI) = 0.42-0.93, adjusted P = 0.019; GC + GG vs. GG: OR = 0.63 95%CI = 0.42-0.93, adjusted P = 0.019; respectively). In addition, stratified analysis revealed that the PPAR gamma rs1801282 SNV was correlated with the risk of GC in subgroups of age >= 61, no smoking, and no alcohol consuming. We also confirmed that the PPAR gamma rs3856806 C > T SNV promoted the risk of GC in women. The PPARGC1A rs8192678 TT genotype decreased the susceptibility of GC in men. The PPARGC1A rs2970847 C > T SNV decreased the susceptibility of GC in the subgroup of BMI >= 24 kg/m(2). The PPARGC1B rs7732671 G > C and rs17572019 G > A SNVs promoted the risk of GC in the subgroup of BMI >= 24 kg/m(2). Conclusion: This study indicates that the PPAR gamma, PPARGC1A, and PPARGC1B SNVs may be associated with the susceptibility of GC in eastern Chinese population. Future studies with larger populations, detailed H. pylori infection status for subgroup analysis, and functional study are needed to further clarify the relationship between these SNVs and GC risk.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn's disease patients
    Shimoda, Fumiko
    Naito, Takeo
    Kakuta, Yoichi
    Kawai, Yosuke
    Tokunaga, Katsushi
    NCBN Controls WGS Consortium, Michio
    Shimoyama, Yusuke
    Moroi, Rintaro
    Shiga, Hisashi
    Nagasaki, Masao
    Kinouchi, Yoshitaka
    Masamune, Atsushi
    Ishibashi-Ueda, Hatsue
    Tomita, Tsutomu
    Noguchi, Michio
    Takahashi, Ayako
    Goto, Yu-ichi
    Yoshida, Sumiko
    Hattori, Kotaro
    Matsumura, Ryo
    Iida, Aritoshi
    Maruoka, Yutaka
    Gatanaga, Hiroyuki
    Sugiyama, Masaya
    Suzuki, Satoshi
    Miyo, Kengo
    Matsubara, Yoichi
    Umezawa, Akihiro
    Hata, Kenichiro
    Kaname, Tadashi
    Ozaki, Kouichi
    Tokuda, Haruhiko
    Watanabe, Hiroshi
    Niida, Shumpei
    Noiri, Eisei
    Kitajima, Koji
    Omae, Yosuke
    Miyahara, Reiko
    Shimanuki, Hideyuki
    Kawai, Yosuke
    Tokunaga, Katsushi
    PHARMACOGENOMICS JOURNAL, 2023, 23 (06): : 141 - 148
  • [42] HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn’s disease patients
    Fumiko Shimoda
    Takeo Naito
    Yoichi Kakuta
    Yosuke Kawai
    Katsushi Tokunaga
    Yusuke Shimoyama
    Rintaro Moroi
    Hisashi Shiga
    Masao Nagasaki
    Yoshitaka Kinouchi
    Atsushi Masamune
    The Pharmacogenomics Journal, 2023, 23 : 141 - 148
  • [43] Analysis of Clinical Indexes and RUNX3, TBKBP1, PPARGC1B Polymorphisms in Chinese Han Patients with Ankylosing Spondylitis
    Liu, Jun
    Lian, Zijian
    Xiao, Yu
    Shi, Lewis L.
    Chai, Wei
    Wang, Yan
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2015, 19 (01) : 37 - 43
  • [44] Analysis of Single Nucleotide Polymorphisms of STK32B, PPARGC1A and CTNNA3 Gene With Sporadic Parkinson's Disease Susceptibility in Chinese Han Population
    Shi, Chang-he
    Cheng, Yuan
    Tang, Mi-bo
    Liu, Yu-tao
    Yang, Zhi-hua
    Li, Fang
    Fan, Yu
    Yang, Jing
    Xu, Yu-ming
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [45] Association between microRNA genetic variants and susceptibility to colorectal cancer in Chinese population
    Hu, Xuejiao
    Li, Lixin
    Shang, Mengqiao
    Zhou, Juan
    Song, Xingbo
    Lu, Xiaojun
    Wang, Jun
    Ying, Binwu
    Wang, Lanlan
    TUMOR BIOLOGY, 2014, 35 (03) : 2151 - 2156
  • [46] Functional Genetic Variants in SPHK1 Affect Susceptibility to Gastric Cancer in a Chinese Population
    Huan, Xiangkun
    He, Yu
    Huang, Chi
    Wang, Younan
    Zhu, Yi
    Xu, Zekuan
    Yang, Li
    Cao, Huaxiang
    CLINICAL LABORATORY, 2017, 63 (09) : 1347 - 1356
  • [47] Gene-Gene interaction between NPY and PPARGC1A on the risk of essential hypertension: the large-scale association study of the Japanese population
    Eto, M.
    Okayama, M.
    Takeshima, T.
    Kumada, M.
    Aonuma, T.
    Nakamura, Y.
    Kajii, E.
    EUROPEAN HEART JOURNAL, 2017, 38 : 867 - 867
  • [48] Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
    Yuqing Li
    Yi Li
    Sara Wedrén
    Guoliang Li
    Tze Howe Charn
    Kartiki Vasant Desai
    Carine Bonnard
    Kamila Czene
    Keith Humphreys
    Hatef Darabi
    Kristjana Einarsdóttir
    Tuomas Heikkinen
    Kristiina Aittomäki
    Carl Blomqvist
    Kee Seng Chia
    Heli Nevanlinna
    Per Hall
    Edison T Liu
    Jianjun Liu
    Breast Cancer Research, 13
  • [49] Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population
    Alexey G. Nikitin
    Dimitry A. Chistiakov
    Larissa O. Minushkina
    Dmitry A. Zateyshchikov
    Valery V. Nosikov
    Heart and Vessels, 2010, 25 : 229 - 236
  • [50] Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population
    Nikitin, Alexey G.
    Chistiakov, Dimitry A.
    Minushkina, Larissa O.
    Zateyshchikov, Dmitry A.
    Nosikov, Valery V.
    HEART AND VESSELS, 2010, 25 (03) : 229 - 236